73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Researchers report encouraging immunotherapy option for relapsed myeloma patients

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli

Researchers report encouraging immunotherapy option for relapsed myeloma patients

by The Mount Sinai HospitalTreatment breakdown of the multiple myeloma patient cohort. (A) Flow chart showing that the initial retrospective query yielded 115 RRMM patients enrolled on a BiAb cli
Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration

Combination drug activates calcium channels to trigger deadly influx of calcium ions inside tumor cells

JANUARY 29, 2024byWileyCredit:Angewandte Chemie International Edition(2024). DOI: 10.1002/anie.202317578Calcium ions are essential for cells, but can be toxic in higher concentration
Early clinical trial data show gene therapy reversing sickle cell anemia

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce

Early clinical trial data show gene therapy reversing sickle cell anemia

by Cincinnati Children's Hospital Medical CenterTechnicians work in the ISO-certified cleanroom laboratory at Cincinnati Children's, where gene-correction therapies are tested and produce
Researchers make major advance with cancer-killing antibody-drug conjugates

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of

Researchers make major advance with cancer-killing antibody-drug conjugates

by Doug Bennett,University of FloridaCredit:Journal of Medicinal Chemistry(2023). DOI: 10.1021/acs.jmedchem.2c01771Building a new precision cancer treatment comes with no shortage of
Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

byBrigham and Women’s HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers and international collaborators identified the association with younger age and advanced stage at diagnosis, c

Syrian refugees are diagnosed with breast cancer younger and with more advanced tumors, study finds

byBrigham and Women’s HospitalCredit: Unsplash/CC0 Public DomainBrigham researchers and international collaborators identified the association with younger age and advanced stage at diagnosis, c
Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c

Changes in RECIST tumor measures correlate linearly with survival in patients treated with checkpoint inhibitors

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainThe Response Evaluation Criteria In Solid Tumors (RECIST), used in many clinical trials to evaluate changes in tumor burden over time, c
Study shows promising results for immunotherapy targeting skin cancer

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type

Study shows promising results for immunotherapy targeting skin cancer

by King's College LondonCSPG4 expression in malignant melanoma and normal tissues.aCSPG4 mRNA expression, derived from RNAseq data, across cell lines of different cancer cell type
Addition of metastasis-directed therapy increases PFS in prostate cancer

Addition of metastasis-directed therapy increases PFS in prostate cancer

by Elana GotkineThe addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival

Addition of metastasis-directed therapy increases PFS in prostate cancer

by Elana GotkineThe addition of metastasis-directed therapy (MDT), consisting of definitive radiation therapy to all sites of disease, to hormone therapy results in improved progression-free survival
New CAR T-cell therapy research shows potential in solid tumors

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in

New CAR T-cell therapy research shows potential in solid tumors

by Peter MacCallum Cancer CenterCredit: Peter MacCallum Cancer CenterPeter Mac researchers have developed a new approach to chimeric antigen receptor (CAR) T-cell therapy which has proven effective in
Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo

Maximizing the potential of 3D-patient tumor avatars for next-generation precision oncology

by Terasaki Institute for Biomedical Innovation3D Patient Tumor Avatars (3D-PTAs) are part of a proposed integrative platform to provide optimal treatment selections for cancer patients. Such a platfo
Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the

Ethnic diversity and disparities in access to genetic testing impact prostate cancer development and treatment

byEuropean Society for Medical OncologyCredit: Unsplash/CC0 Public DomainMore than 1.4 million men were diagnosed with prostate cancer in 2020 globally, but the molecular characteristics of the
Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm

Treatment decisions in new era of individualized therapy for metastatic hormone-sensitive prostate cancer

byDana-Farber Cancer InstituteProstate cancer cells. Credit: NIH Image GalleryOncologists have traditionally prescribed androgen deprivation therapy (ADT) alone for patients with metastatic horm